El año pasado, Universe Pharmaceuticals Inc generó 13.26M USD en su segmento con mejor rendimiento, Sales of TCMD products. China (Mainland) realizó la mayor aportación, representando 17.86M USD el año pasado.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Sales of TCMD products

Sales of third-party products

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Sales of TCMD products

13.26M(74.25%)

14.03M(60.92%)

18.57M(57.48%)

23.99M(59.76%)

29.56M(61.60%)

18.37M(59.84%)

20.90M(62.88%)

17.62M(61.80%)

Sales of third-party products

4.60M(25.75%)

9.00M(39.08%)

13.74M(42.52%)

16.15M(40.24%)

18.42M(38.40%)

12.33M(40.16%)

12.33M(37.12%)

10.89M(38.20%)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

China (Mainland)

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

China (Mainland)

17.86M(100.00%)

23.02M(100.00%)

32.31M(100.00%)

40.14M(100.00%)

47.98M(100.00%)

30.70M(100.00%)

33.23M(100.00%)

28.51M(100.00%)